Download Citation
Article Source:
Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo
Beconi M,
Aziz O,
Matthews K,
Moumné L,
O’Connell C,
et al.
(2012)
Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo.
PLOS ONE 7(9): e44498.
https://doi.org/10.1371/journal.pone.0044498